ENTITY
Chugai Pharmaceutical

Chugai Pharmaceutical (4519 JP)

140
Analysis
Health CareJapan
Chugai Pharmaceutical Company Ltd., manufactures and sells pharmaceuticals in the domestic and international markets through its subsidiaries. The Company develops drugs in the fields of cancer, infectious diseases, bone, blood, and circulatory systems. Chugai Pharmaceutical also conducts research studies on drugs with private and public medical research institutions.
more
Refresh
21 Apr 2017 17:42

The Week That Was in NorthAsia@Smartkarma: Trucks, Pachinko, and Life Insurance

JapanStrong pick-up truck sales in USNick Tanner suggested paying attention to the continued recovery of US pick-up truck sales for Toyo Tire &...

Logo
241 Views
Share
19 Apr 2017 07:32

Japan Earnings - Thumbnail Preview of Those Reporting Early

This week sees the start of Japan’s earnings season with Yaskawa Electric Corp (6506 JP) reporting on 20th and Tokyo Steel Mfg Co Ltd (5423 JP)...

19 Apr 2017 04:07

Chugai – Positive Data for Emicizumab from HAVEN 2

After Alecensa impressed in Phase III trials earlier this week, Chugai (4519 JP) had the added pleasure of seeing emicizumab do well in the second...

bullishMedrx Co Ltd
16 Apr 2017 18:50

Medrx - Japan Biotech Microcap in Potential Big Licensing Deal

Although the Japanese drug industry suffers from a lack of scale, where it is good is in applying manufacturing techniques to develop not just...

12 Apr 2017 17:07

Chugai Pharma (4519) - ALEX Trials for Alecensa a Success

Chugai Pharmaceutical (4519 JP) completed the clean sweep on Phase III trials for Alecensa. The latest data, from the ALEX trial, showed its...

x